Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Choosing the right investment app can be daunting for beginners. We break down the best options to help you start investing confidently.
24,582 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
As markets push higher, investors wonder if a downturn is inevitable. This guide dives into history, current signals,...
When a uranium energy stock pops, investors pause to ask what changed and whether the rally can last. This guide brea...
Meta Platforms appears poised for a potential move toward $700 as earnings beat and AI-driven monetization clash with...
A big earnings event could flip the script for Microsoft stock. This article breaks down why the bold idea of a parab...
U.S. GDP rose at a 1.4% annualized pace in the fourth quarter, a sharp deceleration from earlier quarters. The report...
A new AI-powered marketing platform is offering shares at $0.85 in a Reg A+ round, drawing comparisons to early Nvidi...
The software sector has faced a tough stretch, dragging some quantum plays into the red. This guide dives into whethe...
Net migration into the United States swung negative last year, the first such reversal since the Great Depression, si...
Magic Eden confirms a strategic pivot, winding down Ethereum, Polygon, and Bitcoin NFT marketplaces to double down on...
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
Boards are rethinking CEO selection, prioritizing agility and AI fluency over years on the job. The shift could upend...